News

Biopharma Expands Clinical Program of Lead Drug Candidate to Treat Chronic Cough

September 30, 2021 (Investorideas.com Newswire) Algernon Pharmaceuticals will now pursue Ifenprodil in chronic cough based on encouraging recent study results in a Phase 2 trial.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News

News

Against Bond Market Odds

October 22, 2021 (Investorideas.com Newswire) Such was the S&P 500 correction, how did you like ...